At the heart of medical progress lies the ability to innovate and collaborate. The Genolier Campus, with its state-of-the-art infrastructure and multidisciplinary teams, plays a central role in promoting biomedical innovation and developing new therapeutic approaches.
Thanks to the diversity of its structures and the specialities they house, the Genolier Campus promotes biomedical innovation. This diversity of disciplines promotes what the Anglo-Saxons call ‘cross-fertilisation’ between different areas of medicine, such as medtech and biomolecular sciences.
Fundraising is essential for financing ambitious research projects, enabling innovative solutions to be developed in the laboratory. These financial resources accelerate the transition from scientific discoveries to clinical applications, rapidly improving patient care.
Firstly, because in a significant number of cases, this care is the result of so-called ‘translational’ (i.e. transfer) research. This strategy focuses on the rapid implementation of scientific discoveries from the laboratory into clinical practice. The research carried out on campus improves the quality of patient care by developing innovative and personalised tools, particularly in oncology.